Variable | N (%) |
---|---|
Age (Mean, SD, Median) | 57.0 (13.5) 57 |
Ethnicity | Â |
   Caucasian | 73 (71.6%) |
   African American | 26 (25.5%) |
   Other | 2 (2.0%) |
   Unknown | 1 (1.0%) |
BMI (Mean, SD, Median) | 29.0 (6.5) 28.0 |
Had Prior Breast Cancer Surgery | 89 (87.3%) |
Had Prior Radiation Therapy | 73 (71.6%) |
Had Prior Neoadjuvant Therapy | 16 (15.7%) |
Had Prior Adjuvant Therapy | 63 (61.8%) |
First Line Therapy | Â |
   None Reported | 4 (3.9%) |
   Hormonal Therapy Only | 30 (29.4%) |
   Taxane Based Therapy | 43 (42.0%) |
   Non-Taxane Based Therapy | 25 (25.0%) |
   Had Toxicity Related Discontinuation | 7 (6.9%) |
Received Second Line Therapy | 92 (90.1%) |
   Had Toxicity Related Discontinuation | 6 (6.5%) |